Zurück geht es hier Grüezi! Sie wurden auf finanzen.ch, unser Portal für Schweizer Anleger, weitergeleitet.  Zurück geht es hier.

Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund ID Fonds 125957293 / LU2596924402

11.00 GBP
-0.07 GBP
-0.63 %
12.12.2024
NAV

Nettoinventarwert (NAV)

11.00 GBP -0.07 GBP -0.63 %
Vortag 11.07 GBP Datum 12.12.2024

Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund ID Fonds Kurs - 1 Jahr

  • 1W
  • 3M
  • 1J
  • 3J
  • 5J
  • MAX

Top Kryptowährungen ETPs

Name ISIN Performance
21Shares Sui Staking ETP CH1360612159 431.58%
21Shares Stellar ETP CH1109575535 362.55%
21Shares Ripple XRP ETP CH0454664043 328.80%
21Shares Algorand ETP CH1146882316 238.12%
21Shares Stacks Staking ETP CH1258969042 227.84%
21Shares Cardano ETP CH1102728750 217.69%
21Shares Injective Staking ETP CH1360612134 56.67%
21Shares Immutable ETP CH1360612142 54.85%
Name ISIN Performance
21Shares Ripple XRP ETP CH0454664043 380.65%
21Shares Stellar ETP CH1109575535 326.01%
21Shares Aave ETP CH1135202120 294.24%
21Shares Cardano ETP CH1102728750 154.54%
21Shares Algorand ETP CH1146882316 153.23%
Name ISIN Performance
21Shares Aave ETP CH1135202120 290.47%
21Shares Ripple XRP ETP CH0454664043 282.32%
21Shares Solana staking ETP CH1114873776 245.30%
21Shares Stellar ETP CH1109575535 244.99%
21Shares Fantom ETP CH1168929078 217.01%
Name ISIN Performance
21Shares Solana staking ETP CH1114873776 1’730.28%
21Shares Ripple XRP ETP CH0454664043 513.99%
21Shares Bitcoin Core ETP CH1199067674 496.19%
21Shares Aave ETP CH1135202120 495.86%
21Shares Bitcoin ETP CH0454664001 481.11%

Fundamentaldaten

Valor 125957293
ISIN LU2596924402
Emittent T. Rowe Price Management
Aufgelegt in Luxembourg
Auflagedatum 05.04.2023
Kategorie Branchen: Gesundheitswesen
Währung GBP
Volumen 232’566’430.66
Depotbank J.P. Morgan SE, Luxembourg Branch
Geschäftsjahresende 31.12.
Berichtsstand 11.12.2024

Anlagepolitik

So investiert der Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund ID Fonds: To increase the value of its shares, over the long term, through growth in the value of, and income from, its investments. The fund is actively managed and invests mainly in a diversified portfolio of shares of companies that are involved in the research, development, production, or distribution of products or services related to health sciences. The companies may be anywhere in the world, including emerging markets, with a focus on companies in the United States.

ETP Performance: Select Investment Series III SICAV - T. Rowe Price Health Sciences Equity Fund ID Fonds

Performance 1 Jahr
10.78
Performance 2 Jahre -
Performance 3 Jahre -
Performance 5 Jahre -
Performance 10 Jahre -